Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

AVIENCE ☆ NSE

AVIENCE BIOMEDICALS LTD · code 755092 · INE0V9I01017 · Pharma & Healthcare · series SM · Daily price history

263.85 +12.40 (+4.93%) close on 20 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
55

ISA Signal Score: Neutral

Hold or watch: no clear edge. Based on prices to 2026-11-20. Confidence 60%.

Trend40
Momentum77
Volume41
Risk37
Fundamentals73

Working for it

  • Price is above its 20-day average
  • MACD is positive and strengthening
  • Profit grew 23% year on year
  • Revenue grew 17% year on year

Working against it

  • Price is below its 50-day average

Red flags

  • Thinly traded: average daily turnover is low, so entering or exiting can be hard

Measured reference levels (not forecasts): 20-day low 231.70, 52-week high 414.95, typical daily move 12.74, two typical moves below price 238.37.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityStrongROE 32.4%, ROCE 26.9%, debt 0.92x equity
GrowthFastSales 48.4%, profit 101.3% a year over 2 years
ValuationCheapP/E 12.2 vs sector median 50.7
MomentumNot knownNeeds about 200 days of prices.
RiskHighSwings 78% a year, fell up to 46% from a peak, beta -0.11

Smart Investor Tips: AVIENCE

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • Strong earnings compounding: net profit grew at 101.3% CAGR over 2 years.
  • High capital efficiency: ROE of 32.4% indicates strong returns on shareholder equity.
  • Attractive relative valuation: P/E of 12.2x is at a discount to the sector median of 50.7x.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Deep drawdown (-36.4% from 52-week high). Verify earnings trend and balance-sheet debt before treating a low price as a bargain.
  • High 30-day annualized volatility (55%). Keep initial position sizes smaller and use wider stop-review levels.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceHOLD / POSITIVE ON SUPPORT (Score 59/100)

Consolidating. If buying, accumulate only on dips into support at Rs 225.05 – Rs 251.18 (Ideal ~Rs 238.12). Review if price closes below Rs 208.68; upside resistance near Rs 291.11.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 225.05 – Rs 251.18
Ideal ~Rs 238.12
Rs 251.18 Rs 225.05 Rs 208.68
ATR 4.8%
Rs 291.11 Rs 414.95 1 : 1.8
RSI 55 · Vol 0.83x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change -36.4% · high 414.95 · low 222.00 · max drawdown -46.3%

Live Candlestick & TradingView Chart (AVIENCE)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 20 Nov

P/E12.2sector median 50.7
P/B-price / book value
EPSRs 21.71grew 101.3% a year
Dividend yield-from saved dividend events
Debt to equity0.92xnet debt Rs 28.9 Cr
Sales growth48.4%a year over 2 years
Profit growth101.3%a year over 2 years
Operating margin28.8%net margin 16.7%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 0.12. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Adequate Debt & Cash Position · Score 59/100
Total Debt / Loans Rs 28.9 Cr Increased +Rs 6.77 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 28.9 Cr 38.8% of total assets
Debt to Equity & Interest Cover 0.92x D/E Interest cover: 8.3x EBIT
Operating Cash Flow (OCF) Rs 5.91 Cr OCF/PAT conversion: 68%
Free Cash Flow (FCF) - OCF minus Capex
  • Moderate Debt-to-Equity (0.92x).
  • Borrowings rose +30.6% (+Rs 6.77 Cr) in the latest year.
  • Strong loan interest coverage (8.3x EBIT/Interest).

About AVIENCE BIOMEDICALS

No company description saved yet. Use Profile below to read about this company.

Listed on NSE

Market capNot available
First listedNot available
Face valueNot available
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed
Profile completeness0 of 8Missing: description, industry, listing date, face value, share count, book value, ROE, ROCE

Checked: NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Day range251.45 to 264.00Open 251.45
52-week high414.95 -36.4% from high (25 Jun 2026)
52-week low222.00 +18.9% from low (17 Jul 2026)
Volume31,200 1.9x the 20-day average
RSI (14)52 neutral
Volatility (30d)54.5%annualised
222.00
414.95

Returns

1W+5.2%
1M+3.9%
3M+3.1%
6Mn/a
1Yn/a
YTDn/a

Against the NIFTY 50

PeriodAVIENCENIFTY 50Difference
1M+3.9%+13.1% -9.2 pts
3M+3.1%+6.4% -3.3 pts

Risk over the past year

Volatility78%high
Deepest fall-46.3%from a peak
Beta-0.11moves less than the index
Best day+17.5%20 Jul 2026
Worst day-19.7%17 Jul 2026
Up days40%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 101 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 6 / 9 · Solid Financial Health
3-Step DuPont ROE Identity: High Pricing Power & Margin Leader
Net Margin: 16.7% × Asset Turnover: 0.70x × Equity Multiplier: 2.37x = ROE 32.4%
✓ Positive Net Profit (PAT > 0) Rs 8.75 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 5.91 Cr
⚠ High Cash Conversion (OCF >= 85% of PAT) 68% conversion
⚠ Improving Return on Assets (ROA YoY) 11.7% vs 12.6%
✓ Conservative / Decreasing Debt-to-Equity 0.92x (prev 0.98x)
✓ Healthy Balance Sheet Asset Coverage 5.25x
✓ Institutional Return on Equity (ROE >= 14%) 32.4%
✓ Stable / Expanding Profit Margin YoY 16.7% vs 15.8%
⚠ Asset Turnover Efficiency (Sales / Assets) 0.70x

Quarterly Results (Last 4 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Mar 2025 Sep 2025 Mar 2026 Sep 2026
Sales / Revenue 24.526.825.731.1
Sales QoQ % -+9.6%-4.2%+21.2%
Operating Profit 6.617.257.698.39
Operating Margin (OPM %) 27.0%27.0%29.9%27.0%
Net Profit (PAT) 4.274.544.225.54
Profit QoQ % -+6.3%-7.0%+31.3%
Profit YoY % ---1.2%+22.0%
Net Margin % 17.4%16.9%16.4%17.8%

Sales and profit Rs crore, consolidated

Sales growth+48.4%a year, 2Y
Profit growth+101.3%a year, 2Y
EPS growth+101.3%a year, 2Y
Avg ROE38.8%3 years

Profit and loss

Rs croreFY24FY25FY26
Sales23.844.952.5
Sales growth-+88.5%+16.8%
Operating profit4.1811.515.1
Operating margin17.5%25.6%28.8%
Other income0.410.580.29
Interest0.941.451.70
Depreciation0.620.881.22
Profit before tax3.039.7712.5
Tax rate28.7%27.3%29.8%
Net profit2.167.108.75
Profit growth-+228.7%+23.2%
Net margin9.1%15.8%16.7%
EPS (Rs)5.3617.6121.71

Balance sheet

Rs croreFY24FY25FY26
Equity (net worth)6.2222.731.4
Borrowings15.122.228.9
Cash---
Total assets34.556.474.5
Debt to equity2.43x0.98x0.92x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY24FY25FY26
Operating Cash Flow (OCF)1.023.395.91
Capital Expenditure (Capex)---
Free Cash Flow (FCF = OCF - Capex)---
OCF / Net Profit Conversion0.47x0.48x0.68x
Total Borrowings / Loans15.122.228.9
Cash & Bank Balances---
Trade Receivables (Cr)---
Receivable Days---
Inventories (Cr)---
Inventory Days---

Returns on capital

Rs croreFY24FY25FY26
ROE34.7%49.2%32.4%
ROCE18.6%33.9%26.9%
Interest cover4.22x7.74x8.34x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
LAURUSLABSLAURUS LABS LIMITED 2,294.60 -0.5% - 123,667 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZYDUS LIFESCIENCES LTD 1,200.00 -0.2% - 120,720 31.5 6.1 0.6% 0.6%
GLENMARKGLENMARK PHARMACEUTICALS 2,648.00 +1.5% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD 825.00 +1.9% - 62,284 59.8 - 7.8% 11.7%
GLANDGLAND PHARMA LIMITED 3,331.90 +1.2% - 54,880 53.4 - 8.9% 16.0%
GLAXOGLAXOSMITHKLINE PHARMA LT 2,727.60 +0.5% - 46,208 78.3 26.0 33.2% 17.1%
EMCUREEMCURE PHARMACEUTICALS L 2,337.80 -0.3% - 44,351 47.9 9.0 19.0% 10.2%
SAILIFESAI LIFE SCIENCES LIMITED 1,800.70 +0.7% - 38,250 109.3 15.4 14.0% 15.9%
WOCKPHARMAWOCKHARDT LIMITED 2,184.40 -0.1% - 35,495 166.5 7.2 4.3% 6.4%
GRANULESGRANULES INDIA LIMITED 822.65 +2.7% - 19,939 34.3 3.9 11.7% 11.1%
ALIVUSALIVUS LIFE SCIENCES LTD 1,436.90 -0.9% - 17,609 37.4 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LAB LTD. 2,029.10 -2.7% - 15,411 33.7 6.7 19.7% 27.0%
Sector median- 50.77.012.4%

The 12 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) RSI 52: neutral Volume is 1.9x the 20-day average

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower quarter of its 1-year range and is lower than it was on 54% of days in the past year.

Support (prices below today's)

20-day low225.05-14.7%
60-day low225.05-14.7%
52-week low222.00-15.9%

Resistance (prices above today's)

20-day high272.00+3.1%
50-day average288.76+9.4%
60-day high392.00+48.6%
52-week high414.95+57.3%

Zones buyers often watch

Lower quarter of the 1-year range 222.00 to 270.24 price is inside this zone now
Pullback of 10% to 20% from the high 331.96 to 373.46 A common area for dips inside an uptrend.

Deepest fall from a peak in the past year: -46.3%. Currently -36.4% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average251.18 Price is 5.0% above
50-day average288.76 Price is 8.6% below
200-day average- Needs more history
RSI (14)52Neutral
MACD (12, 26, 9)-8.19Above its signal line (momentum rising)
Volatility (30d)54.5%High yearly swings

Support and resistance

R2272.32
R1268.08
Pivot259.77
S1255.53
S2247.22

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-20 251.45 264.00 251.45 263.85 +4.93% 31,200
2026-11-19 242.30 251.45 242.30 251.45 +4.99% 17,400
2026-11-18 230.00 243.25 225.05 239.50 +3.37% 15,600
2026-11-17 245.90 250.00 230.00 231.70 -3.38% 22,200
2026-11-16 246.00 255.00 238.65 239.80 -4.37% 34,200
2026-11-13 250.60 256.00 245.05 250.75 -0.89% 17,400
2026-11-12 258.00 258.00 253.00 253.00 -3.58% 19,800
2026-11-11 244.50 262.40 242.00 262.40 +4.98% 42,600
2026-11-09 255.00 262.25 249.95 249.95 -2.00% 16,200
2026-11-06 250.10 253.05 248.50 250.00 -1.96% 6,000
2026-11-05 245.00 255.00 245.00 255.00 +4.98% 16,800
2026-11-04 247.30 250.00 242.25 242.90 -2.84% 8,400
2026-11-03 248.10 252.00 248.10 250.00 +2.23% 4,800
2026-11-02 242.55 255.00 242.55 244.55 -3.40% 13,800
2026-10-30 257.10 258.30 251.75 253.15 -4.45% 12,000
2026-10-29 272.00 272.00 263.55 264.95 -2.12% 10,200
2026-10-28 264.40 270.90 264.40 270.70 +4.92% 13,800
2026-10-27 252.00 264.60 252.00 258.00 +2.38% 15,000
2026-10-26 240.00 252.00 235.60 252.00 +5.00% 6,600
2026-10-23 244.00 245.00 235.55 240.00 -3.19% 36,600
2026-10-22 253.00 254.00 247.00 247.90 -2.38% 7,200
2026-10-21 250.00 260.65 249.05 253.95 -1.61% 13,200
2026-10-19 270.00 270.00 258.10 258.10 -3.30% 16,200
2026-10-16 270.50 274.00 263.15 266.90 -3.65% 33,000
2026-10-15 266.50 280.00 262.25 277.00 +1.95% 36,600
2026-10-14 282.10 284.80 270.00 271.70 -3.60% 19,200
2026-10-13 270.40 286.00 269.00 281.85 +0.57% 55,200
2026-10-12 271.75 281.00 268.10 280.25 +2.09% 26,400
2026-10-09 276.60 279.00 272.35 274.50 -0.76% 16,800
2026-10-08 290.00 290.00 276.00 276.60 -3.76% 39,600
2026-10-07 298.00 300.00 286.70 287.40 -0.95% 31,800
2026-10-06 295.50 304.95 273.00 290.15 -1.43% 105,600
2026-10-05 316.20 316.20 291.40 294.35 -9.08% 168,600
2026-10-01 340.05 341.00 323.75 323.75 -9.99% 213,600
2026-09-30 368.00 374.95 355.50 359.70 -0.54% 45,600
2026-09-29 385.50 392.00 356.25 361.65 -3.88% 85,200
2026-09-28 346.00 376.25 333.00 376.25 +10.00% 99,000
2026-09-25 339.95 348.00 333.45 342.05 +1.14% 46,800
2026-09-24 350.00 350.00 334.40 338.20 -4.58% 79,800
2026-09-23 369.50 379.50 351.60 354.45 +2.49% 102,600
2026-09-22 330.55 359.35 321.00 345.85 +5.86% 99,600
2026-09-21 330.10 338.90 321.00 326.70 -4.59% 67,800
2026-09-18 334.00 343.00 331.50 342.40 +2.27% 13,800
2026-09-17 337.45 340.10 320.00 334.80 -0.79% 49,200
2026-09-16 340.10 345.95 325.00 337.45 -3.48% 37,200
2026-09-15 392.00 392.00 346.85 349.60 -9.28% 46,800
2026-09-11 356.10 388.00 322.00 385.35 +11.12% 100,200
2026-09-10 352.95 360.00 342.25 346.80 +3.11% 64,800
2026-09-09 302.00 343.90 302.00 336.35 +14.99% 106,200
2026-09-08 275.00 294.90 274.95 292.50 +6.75% 29,400
2026-09-07 282.00 284.40 272.00 274.00 -0.36% 16,200
2026-09-04 272.00 279.00 270.05 275.00 +1.66% 10,200
2026-09-03 277.00 278.80 269.50 270.50 -0.73% 16,800
2026-09-02 275.00 275.00 265.00 272.50 -0.91% 9,000
2026-09-01 272.70 281.75 272.70 275.00 +3.11% 23,400
2026-08-31 269.00 270.95 264.70 266.70 -1.04% 9,000
2026-08-28 270.70 279.00 265.30 269.50 -0.42% 23,400
2026-08-27 277.00 280.95 270.00 270.65 -1.62% 20,400
2026-08-26 292.95 293.00 275.00 275.10 -1.82% 15,600
2026-08-25 278.95 300.00 275.00 280.20 +4.34% 65,400
2026-08-24 263.90 284.00 263.90 268.55 +4.94% 99,000
2026-08-21 238.65 259.30 238.65 255.90 +6.63% 19,200
2026-08-20 239.25 242.90 233.00 240.00 +2.17% 13,800
2026-08-19 238.00 240.00 232.35 234.90 -1.30% 12,000
2026-08-18 238.00 244.55 238.00 238.00 +0.42% 10,800
2026-08-17 249.95 250.00 233.50 237.00 -4.16% 31,800
2026-08-14 245.50 248.00 244.95 247.30 -1.06% 5,400
2026-08-13 251.00 251.05 245.65 249.95 -0.38% 9,600
2026-08-12 243.25 251.00 242.55 250.90 +1.17% 28,200
2026-08-11 241.25 250.00 240.35 248.00 +0.61% 25,800
2026-08-10 247.25 255.55 246.50 246.50 +0.18% 10,200
2026-08-07 250.05 254.00 246.00 246.05 -0.79% 21,000
2026-08-06 252.30 252.30 248.00 248.00 -2.36% 14,400
2026-08-05 255.00 257.05 250.00 254.00 -0.37% 11,400
2026-08-04 258.05 259.55 253.00 254.95 -1.20% 13,200
2026-08-03 261.00 262.90 257.00 258.05 +0.41% 13,200
2026-07-31 248.00 260.50 243.20 257.00 +4.18% 66,000
2026-07-30 251.25 256.75 244.00 246.70 -4.36% 33,600
2026-07-29 260.00 263.50 256.00 257.95 -0.65% 29,400
2026-07-28 257.50 267.00 257.00 259.65 +0.06% 16,800
2026-07-27 268.95 268.95 256.50 259.50 -0.10% 75,000
2026-07-24 245.00 265.00 238.00 259.75 +3.40% 168,600
2026-07-23 245.45 260.95 240.00 251.20 +2.32% 78,600
2026-07-22 251.00 252.00 239.00 245.50 -2.39% 38,400
2026-07-21 259.00 260.00 244.10 251.50 -3.95% 62,400
2026-07-20 225.95 267.40 225.95 261.85 +17.50% 335,400
2026-07-17 271.00 272.00 222.00 222.85 -19.69% 567,000
2026-07-16 275.40 281.50 270.50 277.50 +1.37% 30,600
2026-07-15 280.00 286.00 271.00 273.75 -2.35% 27,600
2026-07-14 285.00 296.00 278.00 280.35 -1.92% 51,600
2026-07-13 270.10 287.00 268.50 285.85 +2.92% 33,000
2026-07-10 301.10 307.00 275.00 277.75 -4.39% 66,600
2026-07-09 278.00 290.50 278.00 290.50 +4.99% 37,800
2026-07-08 288.90 296.00 276.40 276.70 -4.88% 81,000
2026-07-07 293.10 300.50 290.90 290.90 -5.00% 35,400
2026-07-06 315.25 315.25 306.20 306.20 -5.00% 88,800
2026-07-03 321.20 348.00 321.20 322.30 -4.67% 313,200
2026-07-02 338.10 338.10 338.10 338.10 -4.99% 6,000
2026-07-01 370.00 370.00 355.85 355.85 -4.99% 3,600
2026-06-30 374.55 374.55 374.55 374.55 -5.00% 3,600
2026-06-29 394.25 394.25 394.25 394.25 -4.99% 78,000
2026-06-25 395.20 414.95 395.20 414.95 +99.50% 726,000

News from the last 15 days More

Shareholding pattern

No filing is linked to this stock yet. An admin can import the exchange listing files under Admin > Shareholding tracker.

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.